Estimates Revisions 10x Genomics, Inc.
Stocks
TXG
US88025U1097
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 65.12 USD | +1.96% |
|
+16.10% | +299.26% |
| 08-17 | 10x Genomics Insider Sold Shares Worth $432,279, According to a Recent SEC Filing | MT |
| 08-13 | 10x Genomics Insider Sold Shares Worth $1,155,055, According to a Recent SEC Filing | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- TXG Stock
- Consensus 10x Genomics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
